Crossmark

GPR120 is an important inflammatory regulator in the development of osteoarthritis

Crossref DOI link: https://doi.org/10.1186/s13075-018-1660-6

Published Online: 2018-08-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Yuanfeng

Zhang, Dan

Ho, Ki Wai

Lin, Sien

Suen, Wade Chun-Wai

Zhang, Huantian

Zha, Zhengang

Li, Gang https://orcid.org/0000-0002-3981-2239
Leung, Po Sing
License Information

Text and Data Mining valid from 2018-08-03
More Information

Article History

Received: 25 December 2017

Accepted: 4 July 2018

First Online: 3 August 2018

Ethics approval and consent to participate

: The study was conducted in accordance with the Code of Ethics of the Chinese University of Hong Kong. The animal study in this research was approved by the Animal Experimental Ethics Committee of the Chinese University of Hong Kong (ref. 13/044/GRF-5 and 13/044/GRF-5). The clinical specimen study was approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee (ethical approval code CRE-2013.248) or the First Affiliated Hospital of Guangzhou University of Chinese Medicine Clinical Research Ethics Committee (ethical approval code YJ-2015.034), and informed consent was obtained from each donor.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.